Response to the Letter to the Editor Entitled "Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy". [PDF]
Su X, Wu B, Wang L.
europepmc +1 more source
Membranous nephropathy and hepatitis secondary to syphilis: a case report and literature review. [PDF]
Ashizawa K +15 more
europepmc +1 more source
Circulating Testican-2 and MGT5A are Markers of Membranous Nephropathy. [PDF]
Kim T +20 more
europepmc +1 more source
Anti-PLA2R antibody reduction as a predictor of treatment response in primary membranous nephropathy: a retrospective study. [PDF]
Bashir K +6 more
europepmc +1 more source
FSTIV score is essential for clinical management and predicts outcome of idiopathic membranous nephropathy. [PDF]
Liu Y +8 more
europepmc +1 more source
Efficacy and safety of zuberitamab in the treatment of primary membranous nephropathy: an observational study. [PDF]
Zong L +5 more
europepmc +1 more source
Clinicopathological characteristics and outcomes in patients with diabetic nephropathy coexisting idiopathic membranous nephropathy: a retrospective observational study. [PDF]
Li Z +5 more
europepmc +1 more source
ST-segment elevation myocardial infarction as the first clue to membranous nephropathy: A case report. [PDF]
Wang D, Deng H, He M, He T.
europepmc +1 more source
Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy. [PDF]
Petr V +16 more
europepmc +1 more source
NELL-1-Positive Membranous Nephropathy Following Inhalational Mercury Exposure. [PDF]
Tahillioglu Y +10 more
europepmc +1 more source

